Evaluating the Probability of Previously Unknown Carriage of MRSA at Hospital Admission (original) (raw)

Abstract

We determined the prevalence and risk profile of patients with previously unknown carriage of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission.We conducted a 7-month, prospective case-controlled study in adult inpatients admitted to a university hospital with endemic MRSA. Multivariate conditional logistic regression for data sets matched 1:4 was performed to identify the risk profile of newly identified MRSA carriers.Overall, 399 of 12 072 screened admissions (prevalence, 3.3%) were found colonized (n = 368, 92%) or infected (n = 31, 8%) with MRSA. In 204 cases (prevalence, 1.7%), MRSA carriage was newly identified. Without screening on admission, 49% (196/399) of MRSA carriers would have been missed. We identified nine independent risk factors for newly identified MRSA carriage at admission (adjusted odds ratio): male sex (1.9); age greater than 75 years (2.0); receipt of fluoroquinolones (2.7), cephalosporins (2.1), and carbapenems (3.2) in the last 6 months; previous hospitalization (1.9) or intravenous therapy (1.7) during the last 12 months; urinary catheter at admission (2.0); and intrahospital transfer (2.4). A risk score (range, 0-13) was calculated by adding points assigned to these variables. On the basis of analysis of 1006 patients included in the case-controlled study, the probability of MRSA carriage was 8% (28/342) in patients with a low score (≤1), 19% (92/482) in patients with an intermediate score (2-4), and 46% (84/182) in patients with a high score (≥5). The risk score had good discrimination (c-statistic, 0.73) and showed excellent calibration (P = .88).On-admission prevalence of previously unknown MRSA carriers was high. Applying the risk score to newly admitted patients with an intermediate or high probability of MRSA carriage could allow a more effective MRSA control strategy.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (43)

  1. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicil- lin-susceptible strains. Am J Med. 1996;100:509-516.
  2. Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbid- ity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol. 2001;22:687-692.
  3. Muto CA, Jernigan JA, Ostrowsky BE, et al. Guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococ- cus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003; 24:362-386.
  4. Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ. 2004;329:533-541.
  5. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphy- lococcus aureus. Clin Infect Dis. 2000;31:1380-1385.
  6. Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis. 2002;185:481-488.
  7. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal D. Methi- cillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39:776-782.
  8. Furuno JP, Harris AD, Wright MO, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vanco- mycin-resistant enterococci upon hospital admission. Am J Infect Con- trol. 2004;32:436-440.
  9. Pittet D, Safran E, Harbarth S, et al. Automatic alerts for methicillin- resistant Staphylococcus aureus surveillance-role of a hospital infor- mation system. Infect Control Hosp Epidemiol. 1996;17:496-502.
  10. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:1412- 1416.
  11. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant staphylococcus aureus. J Hosp Infect. 2000;46: 43-49.
  12. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital- wide program to improve compliance with hand hygiene. Lancet. 2000;356:1307-1312.
  13. Blanc DS, Wenger A, Bille J. Evaluation of a novel medium for screening specimens from hospitalized patients to detect methicillin- resistant Staphylococcus aureus. J Clin Microbiol. 2003;41:3499- 3502.
  14. Francois P, Renzi G, Pittet D, et al. A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol. 2004;42:3309-3312.
  15. Garner JS, Jarvis WR, Emori TG, Toran TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988;16: 128-140.
  16. McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology. Arch Intern Med. 1962;110:847-855.
  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: develop- ment and validation. J Chronic Dis. 1987;40:373-383.
  18. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
  19. O'Brien-Pallas L, Cockerill R, Leatt P. Different systems, different costs? An examination of the comparability of workload measurement systems. J Nurs Adm. 1992;22:17-22.
  20. Sax H, Hugonnet S, Harbarth S, Herrault P, Pittet D. Variation in nosocomial infection prevalence according to patient care setting: a hospital-wide survey. J Hosp Infect. 2001;48:27-32.
  21. Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH. The epidemiology of nephrotoxicity associated with conventional ampho- tericin B therapy. Am J Med. 2001;111:528-534.
  22. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Ver- gouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774-781.
  23. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol. 2003; 56:441-447.
  24. Hoefnagels-Schuermans A, Borremans A, Peetermans W, Van Lierde S, Reybrouck G, Van Eldere J. Origin and transmission of methicillin- resistant Staphylococcus aureus in an endemic situation: differences between geriatrics and intensive care. J Hosp Infect. 1997;36:209-222.
  25. Troillet N, Carmeli Y, Samore MH, et al. Carriage of methicillin- resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol. 1998;19:181-185.
  26. Samad A, Banerjee D, Carbarns N, Ghosh S. Prevalence of methicil- lin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. J Hosp Infect. 2002;51:43-46.
  27. Casas I, Esteve M, Andres I, et al. Prevalence and risk factors of methicillin-resistant Staphylococcus aureus carriage at hospital admis- sion. ECCMID 2003; Glasgow. Abstract O 342. European Society of Clinical Microbiology and Infectious Diseases.
  28. Jernigan JA, Pullen AL, Flowers L, Bell M, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylo- coccus aureus at the time of hospital admission. Infect Control Hosp Epidemiol. 2003;24:409-414.
  29. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prev- alence and risk factors for carriage of methicillin-resistant Staphylo- coccus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med. 2003;163:181-188.
  30. Fishbain JT, Lee JC, Nguyen HD, et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus: a blinded study to estab- lish baseline acquisition rates. Infect Control Hosp Epidemiol. 2003; 24:415-421. 275.e22 The American Journal of Medicine, Vol 119, No 3, March 2006
  31. Ho PL. Carriage of methicillin-resistant Staphylococcus aureus, cefta- zidime-resistant Gram-negative bacilli, and vancomycin-resistant en- terococci before and after intensive care unit admission. Crit Care Med. 2003;31:1175-1182.
  32. Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylococcus au- reus? Infect Control Hosp Epidemiol. 2004;25:395-401.
  33. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139:947- 951.
  34. Rezende NA, Blumberg HM, Metzger BS, Larsen NM, Ray SM, McGowan JE Jr. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admis- sion. Am J Med Sci. 2002;323:117-123.
  35. Tacconelli E, Venkataraman L, De Girolami PC, D'Agata EM. Me- thicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired vs. healthcare-associated strains. J Antimicrob Chemother. 2004;53:474- 479.
  36. Murphy S, Denman S, Bennett RG, Greenough WB 3rd, Lindsay J, Zelesnick LB. Methicillin-resistant Staphylococcus aureus coloni- zation in a long-term-care facility. J Am Geriatr Soc. 1992;40:213- 217.
  37. Cox RA, Bowie PE. Methicillin-resistant Staphylococcus aureus col- onization in nursing home residents: a prevalence study in Northamp- tonshire. J Hosp Infect. 1999;43:115-122.
  38. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epide- miol. 1996;17:20-28.
  39. Monnet DL, MacKenzie F, López-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis. 2004;10:1432-1441.
  40. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. 1999;282:1745-1751.
  41. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin- resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2000;21:718-723.
  42. Cooper BS, Medley GF, Stone SP, et al. Methicillin-resistant Staph- ylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A. 2004;101:10223- 10228.
  43. Tomic V, Svetina Sorli P, Trinkaus D, Sorli J, Widmer AF, Trampuz A. Comprehensive strategy to prevent nosocomial spread of methicil- lin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med. 2004;164:2038-2043.